Dr. Field is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4923 Anniston Cir
Tampa, FL 33647- Is this information wrong?
Summary
- Dr. Teresa Field is a hematologist in Tampa, FL. She received her medical degree from University of Wisconsin School of Medicine and Public Health and has been in practice 24 years. She is experienced in hematologic oncology, myelofibrosis, hematopoietic stem cell transplantation, multiple myeloma, and internal medicine.
Education & Training
- University of Wisconsin Hospitals and ClinicsFellowship, Hematology and Medical Oncology, 1996 - 1998
- University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 1993 - 1996
- University of Wisconsin School of Medicine & Public HealthClass of 1993
Certifications & Licensure
- FL State Medical License 1998 - 2025
- WI State Medical License 1997 - 2009
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Clinical Trials
- Donor Bone Marrow Transplant in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders Start of enrollment: 1996 May 01
- Bone Marrow Transplant in Treating Patients With Hematologic Cancers Start of enrollment: 1993 Mar 01
- Autologous or Donor Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma (BMT CTN 0202) Start of enrollment: 2004 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 16 citationsCoping strategies modify risk of depression associated with hematopoietic cell transplant symptomatology.Anna Barata, Brian D. Gonzalez, Steven K. Sutton, Brent J. Small, Paul B. Jacobsen, Teresa Field, Hugo F. Fernandez, Heather S.L. Jim> ;Journal of Health Psychology. 2018 Jul 1
- 6 citationsPhase I trial of histone deacetylase inhibitor panobinostat in addition to glucocorticoids for primary therapy of acute graft-versus-host disease.Lia Perez, Hugo Fernandez, Pedro Horna, Marcie L. Riches, Frederick L. Locke, Teresa Field, John Powers, Eva Sahakian, Alejandro Villagra, Asmita Mishra, Brian C. Bett...> ;Bone Marrow Transplantation. 2018 Apr 18
- 21 citationsIn vivo IL-12/IL-23p40 neutralization blocks Th1/Th17 response after allogeneic hematopoietic cell transplantation.Joseph Pidala, Francisca Beato, Jongphil Kim, Brian C. Betts, Heather S.L. Jim, Elizabeth M. Sagatys, John E. Levine, James L.M. Ferrara, Umut Ozbek, Ernesto Ayala, Ma...> ;Haematologica. 2017 Dec 14
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: